Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -85.00 -2.12% 3,920.00 3,900.00 3,950.00 4,005.00 3,895.00 4,005.00 5,718 16:35:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.3 8.2 139.4 28.1 204

Bioventix Share Discussion Threads

Showing 1276 to 1299 of 1450 messages
Chat Pages: 58  57  56  55  54  53  52  51  50  49  48  47  Older
DateSubjectAuthorDiscuss
29/3/2021
06:52
In fairness the only real negative was the exchange rate loss which was already known. Given turnover is up at a time when patients presenting is on relative hold is fantastic news. Looks as though troponin is proving to be a winner.All set fair for when we get through Covid.
nigeldoug1
29/3/2021
06:44
Will be interesting to see how the market reacts today, with a very un-Bioventix-like drop of ~9% in profit.

"Sales relating to troponin antibodies grew significantly once again during the period." - a shame there isn't any greater visibility in terms of figures on this growth, especially as this is expected to be one of the more important areas for the company over the next 5 years.

"ongoing evidence that patients are choosing not to present to healthcare professionals" - have to wonder how long this state of affairs is likely to continue, although doubtful anyone really knows.

Good to see that the cash-generative nature of the business means they can hike the dividend by 20% in these comparatively lean times.

spann_703
29/3/2021
06:24
Numbers better than I expected and dividend up 20%.
Suet

suetballs
26/3/2021
17:28
Fingers crossed for Monday's announcement. Might not be great but I'm in for the long haul as the model is so appealing.
nigeldoug1
24/3/2021
15:47
I decided that I remembered a pattern to BVXP at results time (Monday).

It would go up beforehand and slump on the announcement - because it was the usual pattern.

So, I would sell on Friday and buy back when it fell on Monday.

I checked back over a couple of years and it isn’t the usual pattern - so I wont!

Now what’ll happen is that it’ll fall back on the Monday announcement!

apad

apad
24/3/2021
15:25
Worth holding just for the dividend
lancasterbomber
24/3/2021
08:48
I am a new holder of BVXP. Pleasantly impressed by this thread. Sensible grown up chaps,
golfers even, having a friendly chat. Some posters on other shares just mouth pointless obscenities.
I also am a buy and hold investor rather than a trader. I seem to have bought this one at the wrong time, but I shall hang on and see what happens.

altom
21/3/2021
09:03
Don’t just do something, stand there.
johnveals
20/3/2021
13:34
Ha - yes spann_703, I am also a largely buy and hold investor. I too have mused about selling part of my holding with the intention of buying back on any weakness. In the end I decided against it, largely on the grounds that I have been pretty hopeless in both anticipating results and second guessing the market reaction to them in several cases recently.
I also bought BVXP at an average of £8.06, have used up all my CGT allowance and so I would need a drop of almost £7 in the share price to make it worthwhile. Possible I know but just too much of a risk for me.
(Yes also my second largest holding after BOTB !)

housemartin2
20/3/2021
13:15
Housemartin2 as recent posts attest, I doubt you're the only one musing in such a fashion.

I keep coming back to a line in the latest results; "we expect our
business will revert to an established trajectory". To me this is foreshadowing a potential dip in the short-term, and I am wary about how the market will react to anything other than the usual growth from BVXP.

Long-term I am still optimistic as to the company's prospects however.

So eschewing my usual buy and hold strategy, I sold 50% of my holding over the past week. This is my second-largest holding behind BOTB, and I suspect what I am trying to do is mitigate some of the risk, and like APAD am looking to buy on any price weakness. I usually get these things wrong however, and the correct approach is probably to hold as usual.

Interesting how long-term I think the company will do well, and yet devoid of any pressures I still sold half of my holding. Writing this down, it doesn't entirely seem like the rational thing to do; investing rationally is not always so easy.

spann_703
20/3/2021
13:13
Why are you looking at revenue/market cap?
This company has very high margins and a low fixed cost base.

trident5
20/3/2021
12:58
I've been doing the same sort of speculating.

At the current share price it takes 20 years of revenue to buy the company - an astoundingly high number.
By comparison my other large holdings are:
BOO is 3.2 years
FEVR is 9 years
TSTL is 9 years

So, I too expect a setback on the results.

BVXP is 16% of my portfolio, but I shall still buy more over 2021 if there is a decent price drop.

GLA
apad

apad
20/3/2021
12:38
Housemartin just reread the June 2020 results.
The impact of the pandemic is alluded to and as you say we may well be in for a bit of a jolt in the 1/2 year numbers. But maybe that is included in current share price - nah - wishful thinking on my part I think.
Perhaps my purchase was slightly premature but once the vaccinations are sorted out this company will imo soon be back to normal.
The interims are out on 29th March - which is a very important date as I will be back on the golf course!
Suet

suetballs
20/3/2021
11:59
I think that these upcoming 1/2 year numbers will be more interesting than usual. I expect that there will have been a decline in the use of tests due to medical systems concentrating on Covid at the expense of other procedures.
However people will still be having suspected heart attacks (Troponin). General tests for Vit D deficiency I would expect to have declined and not made up for any testing on Covid patients (there are other things to worry about with Covid patients even if Vit D deficiency may be present !)

We could be in for a bit of a jolt

(long BVXP)

housemartin2
15/3/2021
08:10
Had a few this am. I like the story.
suet

suetballs
13/3/2021
13:47
Richard Beddard commentary

hTTps://www.ii.co.uk/analysis-commentary/richard-beddard-two-intriguing-shares-ripe-decision-engine-ii515436

pob69
13/3/2021
13:13
This looks a nice little company and very profitable.
Half yearly results due on 29th March.
Suet

suetballs
09/3/2021
12:55
Would be nice for a new leg up soon.
igbertsponk
27/1/2021
09:54
Best and most efficiently run company I've ever encountered. But woeful on PR and getting insitutional interest. Fine by me as I've accumulated over the years.
igbertsponk
27/1/2021
09:51
Yes, this company has never been prolific with announcements... There are possibly two months before the next RNS, being the Interims at the end of March. Until then, we wait...
strollingmolby
27/1/2021
09:47
lets hope so - rubbish share been treading water for far too long!

Always useful to know when BVXP are being discussed elsewhere. So illiquid it normally signals a tick up.

igbertsponk
27/1/2021
09:44
David is welcome to continue posting such events on the thread as it is entirely relevant with BVXP being discussed there (this is why we are here after all), and also how some of us got to first hear of BVXP when the price was around £3. :)

So... are we going to reach an all-time high this week?

strollingmolby
27/1/2021
09:26
Timewasters!!!
igbertsponk
27/1/2021
09:00
Yeah, but you were one coming here slagging off Davidosh for doing it :-)
stepone68
Chat Pages: 58  57  56  55  54  53  52  51  50  49  48  47  Older
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 05:29:14